A Brief Overview of Cholinergic and Phosphodiesterase-5 Inhibitors in Diabetic Bladder Dysfunction
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms251910704 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Georgios Kallinikas und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Konstantopouleion-Patision Hospital, N. Ionia, 14233 Attika, Greece. Hauptthemen laut MEDLINE: Phosphodiesterase 5 Inhibitors, Diabetes Complications. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Diabetic bladder dysfunction (DBD) comprises a wide spectrum of lower urinary tract symptoms that impact diabetic patients’ lives, including urinary frequency, urgency, incontinence, and incomplete bladder emptying. To relieve symptoms, anticholinergics have been widely prescribed and are considered an effective treatment. There is increasing evidence that diabetic patients may benefit from the use of phosphodiesterase 5 (PDE5) inhibitors. This narrative review aims to provide a brief overview of the pathophysiology of DBD along with a focus on cholinergic and phosphodiesterase inhibitors as therapies that benefit DBD. An examination of the literature suggests compelling avenues of research and underscores critical gaps in understanding the mechanisms underlying DBD. New tools and models, especially rodent models, are required to further elucidate the mechanisms of action of current therapies in the treatment of DBS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Urology, Konstantopouleion-Patision Hospital, N. Ionia, 14233 Attika, Greece.
- Department of Molecular Biology and Genetics, Democritus University of Thrace, 68100 Alexandroupolis, Greece.
- Keenan Research Centre for Biomedical Science, Li Ka Shing Knowledge Institute, St. Michael's Hospital, Unity Health Toronto, Toronto, ON M5B 1W8, Canada.
ORCID-Profile: Georgios Haronis, Diomidis Kozyrakis, Amin M Ektesabi
Zitieren
APA
Kallinikas, G., Haronis, G., Kallinika, E., Kozyrakis, D., Rodinos, E., Filios, A., Filios, P., Mityliniou, D., Safioleas, K., Zarkadas, A., Bozios, D., Karmogiannis, A., Konstantinopoulos, V., Konomi, A. M., Ektesabi, A. M., & Tsoporis, J. N. (2024). A Brief Overview of Cholinergic and Phosphodiesterase-5 Inhibitors in Diabetic Bladder Dysfunction. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms251910704
Vancouver
Kallinikas G, Haronis G, Kallinika E, Kozyrakis D, Rodinos E, Filios A, et al. A Brief Overview of Cholinergic and Phosphodiesterase-5 Inhibitors in Diabetic Bladder Dysfunction. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms251910704
BibTeX
@article{Kallinikas2024,
author = {Kallinikas, Georgios and Haronis, Georgios and Kallinika, Eirini and Kozyrakis, Diomidis and Rodinos, Evangelos and Filios, Athanasios and Filios, Panagiotis and Mityliniou, Despoina and Safioleas, Konstantinos and Zarkadas, Anastasios and Bozios, Dimitrios and Karmogiannis, Athanasios and Konstantinopoulos, Vasileios and Konomi, Anna Maria and Ektesabi, Amin M and Tsoporis, James N},
title = {A Brief Overview of Cholinergic and Phosphodiesterase-5 Inhibitors in Diabetic Bladder Dysfunction},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms251910704}
}
EUVIMED